Two scientists performing chemical analysis

Novartis Financial Results - Q3 2022

Novartis announced the company's financial results for the third quarter of 2022.

Sandoz Logo White on Blue

Sandoz spin-off

Novartis has announced an intention to separate the Sandoz business to create a standalone company by way of a 100% spin-off.

Ukraine response

June 01, 2022

Novartis resumes business in Ukraine

Learn More

More statements


Novartis Gene Therapies Global Managed Access Program

Novartis Gene Therapies recommits to Global Managed Access Program for 2021 so that children around the world can benefit from SMA treatment who otherwise would not have access to Zolgensma.

Read More